$NVGS
Navigator Holdings Ltd. Stock $nvgs

$nvgs Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000162828024013304 Filed on March 27, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$141.6M	$550.7M	$123.3M
YoY Change	14.88%	16.24%	-6.81%
Cost Of Revenue	$66.54M	$257.9M	$67.82M
YoY Change	-1.89%	-2.5%	-3.27%
Gross Profit	$75.10M	$292.8M	$55.47M
YoY Change	35.38%	39.93%	-10.8%
Gross Profit Margin	53.02%	53.16%	44.99%
Selling, General & Admin	$8.878M	$31.21M	$8.389M
YoY Change	5.83%	13.75%	8.16%
% of Gross Profit	11.82%	10.66%	15.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$32.83M	$129.2M	$30.56M
YoY Change	7.42%	2.36%	18.97%
% of Gross Profit	43.71%	44.13%	55.09%
Operating Expenses	$41.74M	$160.4M	$38.84M
YoY Change	7.46%	4.61%	16.53%
Operating Profit	$33.35M	$132.4M	$16.63M
YoY Change	100.61%	136.74%	-42.37%
Interest Expense	-$14.01M	-$45.87M	-$4.961M
YoY Change	182.38%	-3201.15%	68.86%
% of Operating Profit	-42.0%	-34.63%	-29.84%
Other Income/Expense, Net	$0.00	-$171.0K	-$212.0K
YoY Change	-100.0%	-19.34%
Pretax Income	$19.20M	$91.20M	$14.71M
YoY Change	30.49%	49.93%	-137.76%
Income Tax	$56.00K	$4.325M	$4.459M
% Of Pretax Income	0.29%	4.74%	30.3%
Net Earnings	$17.75M	$82.26M	$9.968M
YoY Change	78.08%	53.83%	-124.47%
Net Earnings / Revenue	12.53%	14.94%	8.09%
Basic Earnings Per Share		$1.11
Diluted Earnings Per Share	$0.24	$1.10	$0.13
COMMON SHARES
Basic Shares Outstanding	73.21M shares	74.10M shares	76.80M
Diluted Shares Outstanding		74.61M shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$158.2M	$158.2M	$153.2M
YoY Change	3.3%	3.3%	23.32%
Cash & Equivalents	$158.2M	$158.2M	$153.2M
Short-Term Investments
Other Short-Term Assets	$17.07M	$17.59M	$22.60M
YoY Change	-24.49%	-22.16%	-2.36%
Inventory	$9.044M	$9.044M	$8.548M
Prepaid Expenses
Receivables	$37.09M	$37.09M	$27.61M
Other Receivables	$33.93M	$33.40M	$16.36M
Total Short-Term Assets	$255.4M	$255.4M	$228.3M
YoY Change	11.85%	11.85%	6.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.757B	$1.757B	$1.696B
YoY Change	3.6%	3.6%	-3.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$189.6M	$189.6M	$170.5M
YoY Change	11.2%	11.2%	13.07%
Other Assets	$0.00	$0.00	$1.372M
YoY Change	-100.0%	-100.0%	-94.8%
Total Long-Term Assets	$1.947B	$1.947B	$1.868B
YoY Change	4.22%	4.22%	-3.79%
TOTAL ASSETS
Total Short-Term Assets	$255.4M	$255.4M	$228.3M
Total Long-Term Assets	$1.947B	$1.947B	$1.868B
Total Assets	$2.203B	$2.203B	$2.097B
YoY Change	5.05%	5.05%	-2.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.64M	$11.64M	$7.773M
YoY Change	49.79%	49.79%	-32.99%
Accrued Expenses	$27.25M	$27.25M	$29.30M
YoY Change	-6.99%	-6.99%	13.38%
Deferred Revenue	$25.62M		$23.11M
YoY Change	10.86%		24.84%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$120.3M	$120.3M	$209.8M
YoY Change	-42.66%	-42.66%	41.24%
Total Short-Term Liabilities	$185.4M	$185.4M	$270.6M
YoY Change	-31.47%	-31.47%	32.17%
LONG-TERM LIABILITIES
Long-Term Debt	$732.3M	$732.3M	$596.5M
YoY Change	22.78%	22.78%	-22.64%
Other Long-Term Liabilities	$44.84M	$44.84M	$52.17M
YoY Change	-14.05%	-14.05%	-18.73%
Total Long-Term Liabilities	$777.2M	$777.2M	$648.6M
YoY Change	19.81%	19.81%	-22.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$185.4M	$185.4M	$270.6M
Total Long-Term Liabilities	$777.2M	$777.2M	$648.6M
Total Liabilities	$1.012B	$1.012B	$934.2M
YoY Change	8.37%	8.37%	-10.48%
SHAREHOLDERS EQUITY
Retained Earnings	$390.2M		$364.0M
YoY Change	7.2%		15.19%
Common Stock	$800.2M		$799.0M
YoY Change	0.16%		0.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.190B	$1.190B	$1.162B
YoY Change
Total Liabilities & Shareholders Equity	$2.203B	$2.203B	$2.097B
YoY Change	5.05%	5.05%	-2.81%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	$17.75M	$82.26M	$9.968M
YoY Change	78.08%	53.83%	-124.47%
Depreciation, Depletion And Amortization	$32.83M	$129.2M	$30.56M
YoY Change	7.42%	2.36%	18.97%
Cash From Operating Activities	$59.17M	$174.7M	$36.78M
YoY Change	60.87%	34.07%	11.47%
INVESTING ACTIVITIES
Capital Expenditures	$48.00K	$192.0M	$42.94M
YoY Change	-99.89%	319.41%	-4330.54%
Acquisitions
YoY Change
Other Investing Activities	-$13.86M	$15.48M	$28.39M
YoY Change	-148.81%	-80.99%	115.1%
Cash From Investing Activities	-$13.90M	-$176.5M	-$14.56M
YoY Change	-4.47%	-595.18%	-219.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$1.102M	-$48.74M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-65.43M	6.809M	-23.29M
YoY Change	180.93%	-105.08%	-13.03%
NET CHANGE
Cash From Operating Activities	59.17M	174.7M	36.78M
Cash From Investing Activities	-13.90M	-176.5M	-14.56M
Cash From Financing Activities	-65.43M	6.809M	-23.29M
Net Change In Cash	-20.17M	5.031M	-1.066M
YoY Change	1791.84%	-82.63%	-105.79%
FREE CASH FLOW
Cash From Operating Activities	$59.17M	$174.7M	$36.78M
Capital Expenditures	$48.00K	$192.0M	$42.94M
Free Cash Flow	$59.12M	-$17.26M	-$6.159M
YoY Change	-1059.94%	-120.41%	-118.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001581804
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.01
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-36202
CY2023	dei	Entity Registrant Name EntityRegistrantName	NAVIGATOR HOLDINGS LTD.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	1T
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	10 Bressenden Place,
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	London,
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	SW1E 5DH
CY2023	dei	Entity Address Country EntityAddressCountry	GB
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2023	dei	Trading Symbol TradingSymbol	NVGS
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	73208586	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	876
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	Watford, United Kingdom
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153194000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158242000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18245000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34653000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	9367000	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	2437000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21152000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17068000	usd
CY2022Q4	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings	8548000	usd
CY2023Q4	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings	9044000	usd
CY2022Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	1452000	usd
CY2023Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	526000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	16363000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	33402000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	228321000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	255372000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1692494000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1754382000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	198000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	142000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	239000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	332000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	148534000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	174910000	usd
CY2022Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	21955000	usd
CY2023Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	14674000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3625000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2873000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	1372000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	0	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1868417000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1947313000	usd
CY2022Q4	us-gaap	Assets Assets	2096738000	usd
CY2023Q4	us-gaap	Assets Assets	2202685000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	99009000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	120327000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	219000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	914000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7773000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11643000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	24708000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	20847000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4211000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	5488000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	23108000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25617000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	595000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	606000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	159623000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	185442000	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	608338000	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	641975000	usd
CY2022Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	98943000	usd
CY2023Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	90336000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4032000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3500000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4250000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7016000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48140000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41342000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	763703000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	784169000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	923326000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	969611000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021	nvgs	Profit From Sale Of Vessel ProfitFromSaleOfVessel	0	usd
CY2022	nvgs	Profit From Sale Of Vessel ProfitFromSaleOfVessel	4721000	usd
CY2023	nvgs	Profit From Sale Of Vessel ProfitFromSaleOfVessel	4797000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	28881000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27439000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73208586	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73208586	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76804474	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	76804474	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	769000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	733000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	798188000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	799472000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-463000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-152000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	364000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	390221000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1162494000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1190274000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	10918000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	42800000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1173412000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1233074000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2096738000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2202685000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	352922000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	405346000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	493339000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	27004000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46345000	usd
CY2023	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	50043000	usd
CY2021	us-gaap	Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer	26555000	usd
CY2022	us-gaap	Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer	22101000	usd
CY2023	us-gaap	Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer	7355000	usd
CY2021	us-gaap	Revenues Revenues	406481000	usd
CY2022	us-gaap	Revenues Revenues	473792000	usd
CY2023	us-gaap	Revenues Revenues	550737000	usd
CY2021	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	4802000	usd
CY2022	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	5900000	usd
CY2023	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	6923000	usd
CY2021	nvgs	Voyage Expenses VoyageExpenses	71953000	usd
CY2022	nvgs	Voyage Expenses VoyageExpenses	78674000	usd
CY2023	nvgs	Voyage Expenses VoyageExpenses	74509000	usd
CY2021	nvgs	Voyage Expenses From Luna Pool Collaborative Arrangements VoyageExpensesFromLunaPoolCollaborativeArrangements	20913000	usd
CY2022	nvgs	Voyage Expenses From Luna Pool Collaborative Arrangements VoyageExpensesFromLunaPoolCollaborativeArrangements	20716000	usd
CY2023	nvgs	Voyage Expenses From Luna Pool Collaborative Arrangements VoyageExpensesFromLunaPoolCollaborativeArrangements	5561000	usd
CY2021	nvgs	Vessel Operating Expenses VesselOperatingExpenses	131183000	usd
CY2022	nvgs	Vessel Operating Expenses VesselOperatingExpenses	159266000	usd
CY2023	nvgs	Vessel Operating Expenses VesselOperatingExpenses	170952000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	88486000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	126220000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	129202000	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	63581000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31213000	usd
CY2021	us-gaap	Other Income OtherIncome	367000	usd
CY2022	us-gaap	Other Income OtherIncome	364000	usd
CY2023	us-gaap	Other Income OtherIncome	60000	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	409432000	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	413130000	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	413503000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-2951000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	60662000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	137234000	usd
CY2021	nvgs	Foreign Currency Exchange Gain Loss On Senior Secured Bonds ForeignCurrencyExchangeGainLossOnSeniorSecuredBonds	2146000	usd
CY2022	nvgs	Foreign Currency Exchange Gain Loss On Senior Secured Bonds ForeignCurrencyExchangeGainLossOnSeniorSecuredBonds	6589000	usd
CY2023	nvgs	Foreign Currency Exchange Gain Loss On Senior Secured Bonds ForeignCurrencyExchangeGainLossOnSeniorSecuredBonds	0	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-6270000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	791000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	25124000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-7282000	usd
CY2021	nvgs	Loss On Repayment Of Senior Bonds LossOnRepaymentOfSeniorBonds	0	usd
CY2022	nvgs	Loss On Repayment Of Senior Bonds LossOnRepaymentOfSeniorBonds	1102000	usd
CY2023	nvgs	Loss On Repayment Of Senior Bonds LossOnRepaymentOfSeniorBonds	0	usd
CY2021	us-gaap	Interest Expense InterestExpense	38682000	usd
CY2022	us-gaap	Interest Expense InterestExpense	50840000	usd
CY2023	us-gaap	Interest Expense InterestExpense	64898000	usd
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	usd
CY2022	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	212000	usd
CY2023	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	171000	usd
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	302000	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	1082000	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	5707000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-38394000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	35033000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	70590000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1969000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5949000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4325000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11147000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	25794000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	20607000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-29216000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	54878000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	86872000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1748000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1405000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4617000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-30964000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	53473000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	82255000	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.11
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64669567	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77234830	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74096284	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64669567	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77558494	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74607449	shares
CY2021	us-gaap	Profit Loss ProfitLoss	-29216000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	54878000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	86872000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-215000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	311000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-29224000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	54663000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	87183000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30972000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	53263000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	82566000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1748000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1400000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4617000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-29224000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	54663000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	87183000	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	942395000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	202910000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-29216000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1372000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1117454000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5485000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	54878000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-215000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	864000	usd
CY2022	nvgs	Noncontrolling Interest Investment By Non Controlling Interest NoncontrollingInterestInvestmentByNonControllingInterest	5915000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1173412000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	86872000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	311000	usd
CY2023	nvgs	Noncontrolling Interest Investment By Non Controlling Interest NoncontrollingInterestInvestmentByNonControllingInterest	27265000	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	48736000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1284000	usd
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	7334000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1233074000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-29216000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	54878000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	86872000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	791000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	25124000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-7282000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-6270000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	88486000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	126220000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	129202000	usd
CY2021	nvgs	Expenditures For Dry Docking ExpendituresForDryDocking	19944000	usd
CY2022	nvgs	Expenditures For Dry Docking ExpendituresForDryDocking	18338000	usd
CY2023	nvgs	Expenditures For Dry Docking ExpendituresForDryDocking	12424000	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	63581000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	2407000	usd
CY2021	nvgs	Profit From Sale Of Vessel ProfitFromSaleOfVessel	0	usd
CY2022	nvgs	Profit From Sale Of Vessel ProfitFromSaleOfVessel	4721000	usd
CY2023	nvgs	Profit From Sale Of Vessel ProfitFromSaleOfVessel	4797000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1373000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	869000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1284000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3668000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3863000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3716000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11147000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	25794000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	20607000	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3842000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	2363000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7874000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-13661000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16408000	usd
CY2021	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	8007000	usd
CY2022	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	3858000	usd
CY2023	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	-400000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2703000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3958000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	496000	usd
CY2021	nvgs	Increase Decrease In Accrued Income Prepaid Expense And Other Current Assets IncreaseDecreaseInAccruedIncomePrepaidExpenseAndOtherCurrentAssets	-36566000	usd
CY2022	nvgs	Increase Decrease In Accrued Income Prepaid Expense And Other Current Assets IncreaseDecreaseInAccruedIncomePrepaidExpenseAndOtherCurrentAssets	9541000	usd
CY2023	nvgs	Increase Decrease In Accrued Income Prepaid Expense And Other Current Assets IncreaseDecreaseInAccruedIncomePrepaidExpenseAndOtherCurrentAssets	-11013000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3211000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6636000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4501000	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-16412000	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	1204000	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-17039000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	97941000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	130308000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	174702000	usd
CY2021	nvgs	Payments To Acquire Vessels And Equipment PaymentsToAcquireVesselsAndEquipment	3150000	usd
CY2022	nvgs	Payments To Acquire Vessels And Equipment PaymentsToAcquireVesselsAndEquipment	45719000	usd
CY2023	nvgs	Payments To Acquire Vessels And Equipment PaymentsToAcquireVesselsAndEquipment	191727000	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	4000000	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	36558000	usd
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	16183000	usd
CY2022	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	27469000	usd
CY2023	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	30790000	usd
CY2021	nvgs	Payments To Acquire Other Property Plant And Equipment And Intangible PaymentsToAcquireOtherPropertyPlantAndEquipmentAndIntangible	390000	usd
CY2022	nvgs	Payments To Acquire Other Property Plant And Equipment And Intangible PaymentsToAcquireOtherPropertyPlantAndEquipmentAndIntangible	50000	usd
CY2023	nvgs	Payments To Acquire Other Property Plant And Equipment And Intangible PaymentsToAcquireOtherPropertyPlantAndEquipmentAndIntangible	233000	usd
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	17477000	usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
CY2021	nvgs	Proceeds From Sale Of Vessel ProceedsFromSaleOfVessel	4530000	usd
CY2022	nvgs	Proceeds From Sale Of Vessel ProceedsFromSaleOfVessel	38762000	usd
CY2023	nvgs	Proceeds From Sale Of Vessel ProceedsFromSaleOfVessel	20720000	usd
CY2022	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	9263000	usd
CY2023	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	527000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	33057000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	29725000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-176481000	usd
CY2021	nvgs	Proceeds From Secured Term Loan Facilities And Revolving Credit Facilities ProceedsFromSecuredTermLoanFacilitiesAndRevolvingCreditFacilities	18000000	usd
CY2022	nvgs	Proceeds From Secured Term Loan Facilities And Revolving Credit Facilities ProceedsFromSecuredTermLoanFacilitiesAndRevolvingCreditFacilities	139273000	usd
CY2023	nvgs	Proceeds From Secured Term Loan Facilities And Revolving Credit Facilities ProceedsFromSecuredTermLoanFacilitiesAndRevolvingCreditFacilities	323561000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	26000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1874000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3548000	usd
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	61564000	usd
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
CY2021	nvgs	Repurchase Of Share Capital RepurchaseOfShareCapital	0	usd
CY2022	nvgs	Repurchase Of Share Capital RepurchaseOfShareCapital	5485000	usd
CY2023	nvgs	Repurchase Of Share Capital RepurchaseOfShareCapital	48736000	usd
CY2021	nvgs	Settlement Of Derivatives SettlementOfDerivatives	0	usd
CY2022	nvgs	Settlement Of Derivatives SettlementOfDerivatives	11322000	usd
CY2023	nvgs	Settlement Of Derivatives SettlementOfDerivatives	0	usd
CY2021	nvgs	Operating Lease Payments Use Financing Activities OperatingLeasePaymentsUseFinancingActivities	0	usd
CY2022	nvgs	Operating Lease Payments Use Financing Activities OperatingLeasePaymentsUseFinancingActivities	0	usd
CY2023	nvgs	Operating Lease Payments Use Financing Activities OperatingLeasePaymentsUseFinancingActivities	289000	usd
CY2021	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	usd
CY2022	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	usd
CY2023	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	9000000	usd
CY2021	nvgs	Repayment Of Secured Term Loan And Revolving Credit Facilities RepaymentOfSecuredTermLoanAndRevolvingCreditFacilities	77726000	usd
CY2022	nvgs	Repayment Of Secured Term Loan And Revolving Credit Facilities RepaymentOfSecuredTermLoanAndRevolvingCreditFacilities	186430000	usd
CY2023	nvgs	Repayment Of Secured Term Loan And Revolving Credit Facilities RepaymentOfSecuredTermLoanAndRevolvingCreditFacilities	268311000	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	6342000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	6738000	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	6798000	usd
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	5915000	usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	27265000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7334000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-66094000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-128225000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6810000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	48000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2837000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	64952000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	28971000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5048000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59271000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	124223000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153194000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	124223000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153194000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158242000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	33023000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	48600000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	62109000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	579000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	2438000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1802000	usd
CY2023Q4	nvgs	Number Of Vessels In Fleet NumberOfVesselsInFleet	56	vessel
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	8600000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	6500000	usd
CY2023Q4	nvgs	Number Of Revenue Sources NumberOfRevenueSources	3	revenuesource
CY2023	us-gaap	Use Of Estimates UseOfEstimates	Use of Accounting Estimates We prepare our consolidated financial statements in accordance with U.S. GAAP, which requires us to make estimates in the application of our accounting policies based on our best assumptions, judgments and opinions. On a regular basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our consolidated financial statements are presented fairly and in accordance with U.S. GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q4	nvgs	Number Of Different Revenue Sources NumberOfDifferentRevenueSources	2	revenuesource
CY2023Q4	us-gaap	Derivative Instruments In Hedges At Fair Value Net DerivativeInstrumentsInHedgesAtFairValueNet	0	usd
CY2022Q4	us-gaap	Derivative Instruments In Hedges At Fair Value Net DerivativeInstrumentsInHedgesAtFairValueNet	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	14700000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	22000000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-7300000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	25100000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	800000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	27004000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46345000	usd
CY2023	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	50043000	usd
CY2021	us-gaap	Revenues Revenues	406481000	usd
CY2022	us-gaap	Revenues Revenues	473792000	usd
CY2023	us-gaap	Revenues Revenues	550737000	usd
CY2023Q4	nvgs	Number Of Vessels In Fleet Excluding Independently Managed NumberOfVesselsInFleetExcludingIndependentlyManaged	47	vessel
CY2023Q4	us-gaap	Property Subject To Or Available For Operating Lease Number Of Units PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits	9	vessel
CY2022Q4	nvgs	Number Of Vessels In Fleet NumberOfVesselsInFleet	44	vessel
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	20600000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	25800000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11100000	usd
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	148665000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	150209000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	148534000	usd
CY2021	nvgs	Contributions To Equity Method Investments ContributionsToEquityMethodInvestments	4000000	usd
CY2022	nvgs	Contributions To Equity Method Investments ContributionsToEquityMethodInvestments	0	usd
CY2023	nvgs	Contributions To Equity Method Investments ContributionsToEquityMethodInvestments	35000000	usd
CY2021	nvgs	Equity Method Investment Additions EquityMethodInvestmentAdditions	2580000	usd
CY2022	nvgs	Equity Method Investment Additions EquityMethodInvestmentAdditions	0	usd
CY2023	nvgs	Equity Method Investment Additions EquityMethodInvestmentAdditions	1559000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11147000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	25794000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	20607000	usd
CY2021	nvgs	Dividend Distribution From Joint Venture DividendDistributionFromJointVenture	16183000	usd
CY2022	nvgs	Dividend Distribution From Joint Venture DividendDistributionFromJointVenture	27469000	usd
CY2023	nvgs	Dividend Distribution From Joint Venture DividendDistributionFromJointVenture	30790000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	150209000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	148534000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	174910000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11100000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4156000	usd
CY2022Q4	nvgs	Long Term Debt Gross Current LongTermDebtGrossCurrent	101558000	usd
CY2023Q4	nvgs	Long Term Debt Gross Current LongTermDebtGrossCurrent	123024000	usd
CY2022Q4	nvgs	Long Term Debt Gross Non Current LongTermDebtGrossNonCurrent	660489000	usd
CY2023Q4	nvgs	Long Term Debt Gross Non Current LongTermDebtGrossNonCurrent	687473000	usd
CY2021Q3	nvgs	Guarantor Obligation Number Of Debt Facilities Guaranteed GuarantorObligationNumberOfDebtFacilitiesGuaranteed	4	facility
CY2022Q4	nvgs	Long Term Debt Gross Current LongTermDebtGrossCurrent	101558000	usd
CY2023Q4	nvgs	Long Term Debt Gross Current LongTermDebtGrossCurrent	123024000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	2549000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	2697000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	99009000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	120327000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4011000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	656478000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	683317000	usd
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	500000	usd
CY2020Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	2000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-30964000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	53473000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	82255000	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64669567	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77234830	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74096284	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	323664	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	511165	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64669567	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77558494	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74607449	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33176	shares
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	819919	usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	799902	usd
CY2021	us-gaap	Restricted Stock Expense RestrictedStockExpense	1373292	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	310856	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.37
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.24
CY2022	nvgs	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue	27200	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	320856	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.99
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	262412	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	15.45
CY2023	nvgs	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue	1180854	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	35875	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	22.35
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	547393	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.25
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1207654	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	547393	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.25
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M26D
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	422936	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14240	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	274981	shares
CY2023Q4	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	94931000	usd
CY2023Q4	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	0	usd
CY2023Q4	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	0	usd
CY2023Q4	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	0	usd
CY2023Q4	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	0	usd
CY2023Q4	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	0	usd
CY2023Q4	us-gaap	Other Commitment OtherCommitment	94931000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1027000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1279000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1066000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1274000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4646000	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	218982000	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	393895000	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	149624000	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	68813000	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	93931000	usd
CY2023Q4	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	84829000	usd
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	1010074000	usd
CY2023Q4	us-gaap	Other Commitment OtherCommitment	95000000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4400000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2900000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4300000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3600000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1200000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1200000	usd
CY2023	nvgs	Lessee Operating Lease Number Of Contracts LesseeOperatingLeaseNumberOfContracts	3	contract
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0295
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0287
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M1D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M17D
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	924000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1027000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1246000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1279000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1209000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1066000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1211000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1274000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4590000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4646000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	339000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	232000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4251000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4414000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	219000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	914000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4032000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3500000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-38394000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	35033000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	70590000	usd
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2021	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2022	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	74000	usd
CY2023	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	13000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1969000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5949000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4325000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1264000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2107000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1951000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	705000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3842000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2374000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1969000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5949000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4325000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7000000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	4300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17029000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	13522000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	116000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	205000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17145000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13727000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	17145000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13727000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	21122000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	20002000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	273000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	741000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	21395000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	20743000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	4250000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7016000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6526000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8638000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153194000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158242000	usd
CY2023	nvgs	Line Of Credit Facility Covenant Cash And Cash Equivalents Percentage Of Net Debt Or Total Debt Minimum LineOfCreditFacilityCovenantCashAndCashEquivalentsPercentageOfNetDebtOrTotalDebtMinimum	0.05
CY2021	nvgs	Related Party Transactions Net Income Expense RelatedPartyTransactionsNetIncomeExpense	-2193000	usd
CY2022	nvgs	Related Party Transactions Net Income Expense RelatedPartyTransactionsNetIncomeExpense	-3203000	usd
CY2023	nvgs	Related Party Transactions Net Income Expense RelatedPartyTransactionsNetIncomeExpense	-3376000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73208586	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73208586	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	76804474	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76804474	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023	nvgs	Common Stock Voting Rights Number Of Votes Per Share CommonStockVotingRightsNumberOfVotesPerShare	1	vote

Files In Submission

Name	View Source	Status
0001628280-24-013304-index-headers.html	Edgar Link	pending
0001628280-24-013304-index.html	Edgar Link	pending
0001628280-24-013304.txt	Edgar Link	pending
0001628280-24-013304-xbrl.zip	Edgar Link	pending
a414policyfortherecoveryof.htm	Edgar Link	pending
ex121certificationpursuant.htm	Edgar Link	pending
ex122certificationpursuant.htm	Edgar Link	pending
ex131pursuanttosection906o.htm	Edgar Link	pending
ex132pursuanttosection906o.htm	Edgar Link	pending
ex151consentofindependentr.htm	Edgar Link	pending
ex152consentofindependentr.htm	Edgar Link	pending
ex22descriptionofsecuritie.htm	Edgar Link	pending
ex412executedusd200mtermlo.htm	Edgar Link	pending
ex413ing-navgasjv151mfacil.htm	Edgar Link	pending
ex81subsidiariesandequitym.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
image_2.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvgs-20231231.htm	Edgar Link	pending
nvgs-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
nvgs-20231231_def.xml	Edgar Link	unprocessable
nvgs-20231231_cal.xml	Edgar Link	unprocessable
nvgs-20231231_lab.xml	Edgar Link	unprocessable
nvgs-20231231_pre.xml	Edgar Link	unprocessable
nvgs-20231231_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVGS
Navigator Holdings Ltd. Stock $nvgs

2023 Q4 Form 20-F Financial Statement

#000162828024013304 Filed on March 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVGS Navigator Holdings Ltd. Stock $nvgs

2023 Q4 Form 20-F Financial Statement

#000162828024013304 Filed on March 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVGS
Navigator Holdings Ltd. Stock $nvgs